-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E93HoWGOHBPydug5RFy9UcenwLWdA5zdPg6JlIeX9gCfJBAGs6hMrPOSiaRMSGYL 9oo/8eIhNmLvXbc7PuEt1w== 0001127602-09-002566.txt : 20090204 0001127602-09-002566.hdr.sgml : 20090204 20090204163910 ACCESSION NUMBER: 0001127602-09-002566 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090202 FILED AS OF DATE: 20090204 DATE AS OF CHANGE: 20090204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOHAPATRA SURYA N CENTRAL INDEX KEY: 0001222671 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 09568744 BUSINESS ADDRESS: STREET 1: QUEST DIAGNOSTICS INC STREET 2: ONE MALCOLM AVE CITY: TETERBORO STATE: NJ ZIP: 07608 BUSINESS PHONE: 973-520-2187 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2009-02-02 0001022079 QUEST DIAGNOSTICS INC DGX 0001222671 MOHAPATRA SURYA N C/O QUEST DIAGNOSTICS INCORPORATED 3 GIRALDA FARMS MADISON NJ 07940 1 1 Chairman, President & CEO Common Stock 2009-02-02 4 M 0 10884 49.2513 A 176947 D Common Stock 2009-02-02 4 S 0 10884 49.75 D 166063 D Common Stock 5094 I 401(k)/sdcp Stock Options (Right to Buy) 49.2513 2009-02-02 4 M 0 10884 0 D 2006-02-08 2009-02-03 Common Stock 10884 0 D The exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 21, 2008. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Surya N. Mohapatra 2009-02-04 -----END PRIVACY-ENHANCED MESSAGE-----